Global Thin Film Delivery Drug Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Thin Film Delivery Drug Market Research Report 2024
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
According to Mr Accuracy reports new survey, global Thin Film Delivery Drug market is projected to reach US$ 9099.6 million in 2029, increasing from US$ 6345 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thin Film Delivery Drug market research.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thin Film Delivery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
Oral Thin Film
Transdermal Film
Others
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Thin Film Delivery Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Thin Film Delivery Drug market is projected to reach US$ 9099.6 million in 2029, increasing from US$ 6345 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thin Film Delivery Drug market research.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Thin Film Delivery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
Oral Thin Film
Transdermal Film
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Thin Film Delivery Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices